As of 2025-09-17, the Fair Value of Alnylam Pharmaceuticals Inc (ALNY) is -33.61 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 451.73 USD, the upside of Alnylam Pharmaceuticals Inc is -107.44%.
With the market price of 451.73 USD and our fair value calculation, Alnylam Pharmaceuticals Inc (ALNY) is not a good investment. Investing in Alnylam stocks now will result in a potential loss of 107.44%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -858.30 | -852.80 | -1,131.20 | -440.24 | -278.16 | -712.14 |
| YoY growth | 3.14% | 0.64% | -32.65% | 61.08% | 36.82% | 13.81% |
| Market Cap (mil) | 59,212.11 |
| P/E | |
| Forward P/E |
| EPS | -2.43 |
| Avg earnings growth rate | 13.81% |
| TTM earnings | -319.09 |